Effect of Curcumin on Systemic Lupus Erythematosus
Sponsor: Loma Linda University
Terminated
COVID and lack of support staff 2. lack of support staff to conduct the study
Other terminated trials from Loma Linda University
Other Systemic Lupus Erythematosus trials with similar outcome
Listed as NCT03953261, this PHASE2 trial focuses on Systemic Lupus Erythematosus and remains terminated or withdrawn. Sponsored by Loma Linda University, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2021 — Sep 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE2
▶ Show 4 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Dec 2019 — Oct 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Loma Linda University
For direct contact, visit the study record on ClinicalTrials.gov .